Implant treatment in patients with osteoporosis

Medicina Oral, Patologia Oral y Cirugia Bucal

Volumn 15, Issue 1, 2010, Pages

  Mellado Valero, Ana ^a   Ferrer García, Juan Carlos ^b,c   Calvo Catalá, Javier ^c,d   Labaig Rueda, Carlos ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

^c UNIVERSITY OF VALENCIA   (Spain)

^d Section of Reumathology   (Spain)

Author keywords

Biphosphonates; Implant; Osseointegration; Osteoporosis

Indexed keywords

ALENDRONIC ACID; ANGIOGENESIS INHIBITOR; BISPHOSPHONIC ACID DERIVATIVE; CARBOXY TERMINAL TELOPEPTIDE; CHLORHEXIDINE; CLINDAMYCIN; ESTROGEN; METRONIDAZOLE; PAMIDRONIC ACID; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STEROID; ZOLEDRONIC ACID;

ADVERSE OUTCOME; ANTIANGIOGENIC ACTIVITY; BINDING AFFINITY; BONE DENSITY; BONE MINERAL; BONE REGENERATION; BONE TUMOR; BREAST CANCER; DISEASE MODEL; DRUG ACCUMULATION; DRUG CONTRAINDICATION; DRUG EFFECT; DRUG MANUFACTURE; DRUG MECHANISM; ESTROGEN DEFICIENCY; ESTROGEN THERAPY; FRACTURE; HUMAN; HYPERCALCEMIA; INFORMED CONSENT; JAW OSTEONECROSIS; MULTIPLE MYELOMA; NONHUMAN; OSTEOLYSIS; OSTEOPOROSIS; PAGET BONE DISEASE; POSTMENOPAUSE; PROSTATE CANCER; PROSTHESIS FAILURE; REVIEW; RISK FACTOR; RISK REDUCTION; TOOTH PROSTHESIS; TREATMENT CONTRAINDICATION;

DENTAL IMPLANTS; DIPHOSPHONATES; HUMANS; JAW DISEASES; OSSEOINTEGRATION; OSTEOPOROSIS; PRACTICE GUIDELINES AS TOPIC;

EID: 74549144997     PISSN: 16984447     EISSN: 16986946     Source Type: Journal    
DOI: 10.4317/medoral.15.e52     Document Type: Review

References (20)

1. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy. Osteoporosis: prevention, diagnosis and treatment. JAMA. 2001;285:785-95.
2. Stein E, Shane E. Secondary osteoporosis. Endocrinol Metab Clin North Am. 2003;32:115-34.
3. Laroche M. Treatment of osteoporosis: all the questions we still cannot answer. Am J Med. 2008;121:744-7.
4. Duarte PM, César Neto JB, Gonçalves PF, Sallum EA, Nociti FH. Estrogen deficiency affects bone healing around titanium implants: a histometric study in rats. Implant Dent. 2003;12:340-6.
5. Giro G, Gonçalves D, Sakakura CE, Pereira RM, Marcantonio Júnior E, Orrico SR. Influence of estrogen deficiency and its treatment with alendronate and estrogen on bone density around osseointegrated implants: radiographic study in female rats. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008;105:162-7.
6. De Melo L, Piattelli A, Lezzi G, D'Avila S, Zenóbio EG, Shibli JA. Human histologic evaluation of a six-year-old threaded implant retrieved from a subject with osteoporosis. J Contemp Dent Pract. 2008;9:99-105.
7. Shibli JA, Grande PA, D'Avila S, Iezzi G, Piattelli A. Evaluation of human bone around a dental implant retrieved from a subject with osteoporosis. Gen Dent. 2008;56:64-7.
8. Shibli JA, Aguiar KC, Melo L, D'Avila S, Zenóbio EG, Faveri M, et al. Histological comparison between implants retrieved from patients with and without osteoporosis. Int J Oral Maxillofac Surg. 2008;37:321-7.
9. Becker W, Hujoel PP, Becker BE, Willingham H. Osteoporosis and implant failure: an exploratory case-control study. J Periodontol. 2000;71:625-31.
10. Slagter KW, Raghoebar GM, Vissink A. Osteoporosis and edentulous jaws. Int J Prosthodont. 2008;21:19-26.
11. Amorim MA, Takayama L, Jorgetti V, Pereira RM. Comparative study of axial and femoral bone mineral density and parameters of mandibular bone quality in patients receiving dental implants. Osteoporos Int. 2007;18:703-9.
12. Friberg B, Ekestubbe A, Mellström D, Sennerby L. Brånemark implants and osteoporosis: a clinical exploratory study. Clin Implant Dent Relat Res. 2001;3:50-6.
13. Serra MP, Llorca CS, Donat FJ. Oral implants in patients receiving bisphosphonates: a review and update. Med Oral Patol Oral Cir Bucal. 2008;13:E755-60.
14. Pazianas M, Miller P, Blumentals WA, Bernal M, Kothawala P. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics. Clin Ther. 2007;29:1548-58.
15. Gómez Font R, Martínez García ML, Olmos Martínez JM. Osteochemonecrosis of the jaws due to bisphosphonate treatments. Update. Med Oral Patol Oral Cir Bucal. 2008;13:E318-24.
16. Woo SB, Hellstein JW, Kalmar JR. Narrative [corrected] review: bisphosphonates and osteonecrosis of the jaws. Ann Intern Med. 2006 May 16;144(10):753-61. Review. Erratum in: Ann Intern Med. 2006;145:235.
17. Khosla S, Burr D, Cauley J, Dempster DW, Ebeling PR, Felsenberg D, et al. Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res. 2007;22:1479-91.
18. Grant BT, Amenedo C, Freeman K, Kraut RA. Outcomes of placing dental implants in patients taking oral bisphosphonates: a review of 115 cases. J Oral Maxillofac Surg. 2008;66:223-30.
19. Fugazzotto PA, Lightfoot WS, Jaffin R, Kumar A. Implant placement with or without simultaneous tooth extraction in patients taking oral bisphosphonates: postoperative healing, early follow-up, and the incidence of complications in two private practices. J Periodontol. 2007;78:1664-9.
20. Bagán J, Blade J, Cozar JM, Constela M, García Sanz R, Gómez Veiga F, et al. Recommendations for the prevention, diagnosis, and treatment of osteonecrosis of the jaw (ONJ) in cancer patients treated with bisphosphonates. Med Oral Patol Oral Cir Bucal. 2007;12:E336-40.